Association of cholesteryl ester transfer protein -629C>A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients

Cell Biochemistry and Function

Volumn 27, Issue 7, 2009, Pages 452-457

  Tanrikulu, Sevda ^a   Ademoglu, Evin ^a   Gurdol, Figen ^a   Mutlu Turkoglu, Umit ^a   Bilge, Ahmet Kaya ^a   Nisanci, Yilmaz ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

629C>A polymorphism; CETP; Coronary artery disease; HDL cholesterol

Indexed keywords

ADENOSINE; CHOLESTEROL ESTER TRANSFER PROTEIN; CYTIDINE; HIGH DENSITY LIPOPROTEIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENDER; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN CELL; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SMOKING; TURKEY (REPUBLIC);

ADULT; AGED; CASE-CONTROL STUDIES; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; DEMOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES;

EID: 70350576539     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1593     Document Type: Article

References (32)

1. Inazu A, Brown ML, Hesler CB, et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 1990; 323: 1234-1238. (Pubitemid 20366528)
2. Zhong S, Sharp DS, Grove JS, et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 1996; 97(12): 2917-2923. (Pubitemid 26197108)
3. Marotti KR, Castle CK, Boyle TP, Lin AH, Murray RW, Melchior GW. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 1993; 364: 73-75. (Pubitemid 23233459)
4. Hirano K, Yamashita S, Matsuzawa Y. Pros and cons of inhibiting cholesteryl ester transfer protein. Curr Opin Lipidol 2000; 11: 589-596.
5. Yamashita S, Hirano K, Sakai N, Matsuzawa Y. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein. Biochim Biophys Acta 2000; 1529(1-3): 257-275.
6. Fristal E, Klerkx AH, Le Goff W, et al. Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study. Hum Mol Genet 2005; 14: 2607-2618.
7. Dachet C, Poirier O, Cambien F, Chapman J, Rouis M. New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation. Arterioscler Thromb Vasc Biol 2000; 20: 507-515.
8. Corbex M, Poirier O, Fumeron F, et al. Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction. Genet Epidemiol 2000; 19: 64-80.
9. Borggreve SE, Hillege HL, Wolffenbuttel BH, et al. The effect of cholesteryl ester transfer protein -629C>A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides. J Clin Endocrinol Metab 2005; 90: 4198-4204.
10. Hodoǧlugil U, Williamson DW, Huang Y, Mahley RW. An interaction between the TaqIB polymorphism of cholesterol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks. Clin Genet 2005; 68(2): 118-127. (Pubitemid 40990622)
11. Ozsait B, Kömürcü Bayrak E, Poda M, et al. CETP TaqIB polymorphism in Turkish adults: association with dyslipidemia and metabolic syndrome. Anadolu Kardiyol Derg 2008; 8(5): 324-330.
12. Yilmaz H, Isbir T, Agachan B, Karaali ZE. Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients. Cell Biochem Funct 2005; 23(1): 23-28. (Pubitemid 40065169)
13. Colombo MG, Andreassi MG, Paradossi U, et al. Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298->Asp polymorphism) to the presence, extent, and severity of coronary artery disease. Heart 2002; 87: 525-528. (Pubitemid 34547974)
14. National Institutes of Health NIH Publication. Website: http:// www.nhlbi.nih.gov/guidelines/obesity/index.htm, 2009.
15. National Institutes of Health NIH Publication. Website: http:// www.nhlbi.nih.gov/guidelines/cholesterol/atp3xsum.pdf, 2009.
16. Mahley RW, Palaoglu KE, Atak Z, et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995; 36: 839-859.
17. Bozkaya TY, Ozerkan F. HDL Kolesterol Düşüklü ǧü. J Int Med Sci (Turkiye Klinikleri) 2006; 2: 10-17.
18. Mahley RW, Palaoglu KE, Atak Z, et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995; 36: 839-859.
19. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Br Med J 1989; 298: 784-788.
20. Vega GL, Grundy SM. Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for coronary heart disease. Curr Opin Lipidol 1996; 7: 209-216. (Pubitemid 26280230)
21. Mahley RW, Arslan P, Pekcan G, et al. Plasma lipids in Turkish children: impact of puberty, socioeconomic status, and nutrition on plasma cholesterol and HDL. J Lipid Res 2001; 42: 1996-2006.
22. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 2001; 156: 1-10. (Pubitemid 32429589)
23. Bersot TP, Vega GL, Grundy SM, et al. Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population. J Lipid Res 1999; 40: 432-438. (Pubitemid 29116146)
24. Mahley RW, Pépin J, Palaoglu KE, et al. Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase: high density lipoprotein characterization and gender-specific effects of apolipoprotein E genotype. J Lipid Res 2000; 41: 1290-1301. (Pubitemid 30666894)
25. Koycu B, Kara T, Camlidag O, et al. Risk factors for cardiovascular diseases in Turks in Amsterdam and in Ankara [Article in Dutch]. Ned Tijdschr Geneeskd 1997; 141: 882-888.
26. Lüttmann S, von Eckardstein A,WeiW, et al. Electrophoretic screening for genetic variation in apolipoprotein C-III. Identification of a novel apoC-III variant, apoC-III (Asp45→Asn), in a Turkish patient. J Lipid Res 1994; 35: 1431-1440.
27. Le Goff W, Guerin M, Chapman MJ. Pharmacological modulation of cholesteryl ester transfer protein: a new therapeutic target in atherogenic dyslipidemia. Pharmacol Ther 2004; 101: 17-38. (Pubitemid 38068523)
28. Barter PJ, Brewe HBJ, Chapman MJ, Hennekens CH, Rader DJ, Tall AR. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol 2003; 23: 160-167.
29. Eiriksdottir G, Bolla MK, Thorsson B, Sigurdsson G, Humphries SE, Gudnason V. The -629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men. Atherosclerosis 2001; 159: 187-192.
30. Tai ES, Ordovas JM, Corella D, et al. The TaqIB and -629C>A polymorphisms at the cholesteryl ester transfer protein locus: associations with lipid levels in a multiethnic population. The 1998 Singapore National Health Survey. Clin Genet 2003; 63(1): 19-30.
31. Lu H, Inazu A, Moriyama Y, et al. Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism. J Mol Med 2003; 81: 246-255. (Pubitemid 36578923)
32. Le GoffW, Guerin M, Nicaud V, et al. A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels. Interaction with the TaqIB and -629C/A polymorphisms. Atherosclerosis 2002; 161: 269-279.